Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics.
Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments.
Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
Company Details
- Employees
- 29
- Founded
- -
- Address
- Via Giuseppe Massarenti, 61, Bologna,em.rom. 40138,italy
- Phone
- 390510397670
- in****@****ply.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cellply.com
- Keywords
- microsystems, cell analysis, drug testing, cell therapy, immunotherapy, single-cell, potency, cell function.
- HQ
- Bologna, Em.Rom.
Cellply Questions
Cellply's helpline number is 390510397670
Cellply's website is cellply.com
Cellply's LinkedIn profile is https://it.linkedin.com/company/cellply
Cellply has
29 employees.
View email and phone details for 29
employees at Cellply.
Cellply's industry is
Biotechnology Research
Cellply's top competitors are
Alfasigma,
Aavantgarde,
Molmed Now Part Of Agc Biologics,
Alia Therapeutics,
Altheia Science,
Sibylla Biotech,
Aurora-Tt,
Resalis Therapeutics,
Genenta Science (Nasdaq: Gnta),
Prebiomics.
Cellply's support email address is info@cellply.com
Cellply's categories are Biotechnology Research
Cellply's founding year is 2013
